Combination Therapy of Interleukin-12 and Interleukin-2 to Treat Advanced Cancer

NCT00005655 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

39

Enrollment

NIH

Sponsor class

Conditions

Kidney Neoplasm
Lung Neoplasm
Sarcoma
Breast Neoplasm

Interventions

BIOLOGICAL: rh IL-12
BIOLOGICAL: rh IL-2

Sponsor

National Cancer Institute (NCI)